{"name": "Epivios",
 "permalink": "epivios",
 "crunchbase_url": "http://www.crunchbase.com/company/epivios",
 "homepage_url": "http://epivios.de/en/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "nicole.groth@epivios.com",
 "phone_number": "(049) 0211/8104341",
 "description": "",
 "created_at": "Thu Jul 12 03:32:45 UTC 2012",
 "updated_at": "Thu Jul 12 03:34:00 UTC 2012",
 "overview": "\u003Cp\u003EEpivios GmbH, a D\u00fcsseldorf, Germany-based developer of molecular diagnostic cancer tests. Led by Nicole Groth and Dr Simeon Santourlidis, Epivios was founded in 2011 as a spin-off of the Heinrich Heine University of D\u00fcsseldorf. Its interdisciplinary team, comprising doctors and biologists, has been working since 2009 on innovative epigenetic procedures for cancer diagnosis. The company\u2019s epigenetic platform technology includes a new kind of standardization tool that allows the comparison of samples with differing genetic constitution for the first time. Epivios\u00b4s new procedure also analyzes sequences, which spread across the entire genome.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       83],
      "assets/images/resized/0020/0374/200374v1-max-150x150.png"],
     [[157,
       87],
      "assets/images/resized/0020/0374/200374v1-max-250x250.png"],
     [[157,
       87],
      "assets/images/resized/0020/0374/200374v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2012/07/epivios-receives-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Epivios Receives Funding",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2012,
    "funded_month": 7,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "High-Tech Gruenderfonds",
         "permalink": "high-tech-gruenderfonds",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/8109/28109v4-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0002/8109/28109v4-max-250x250.jpg"],
             [[450,
               125],
              "assets/images/resized/0002/8109/28109v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "D\u00fcsseldorf Moorenstr. 5, ",
    "address2": "Geb. 14.80",
    "zip_code": "40225 ",
    "city": "D\u00fcsseldorf",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}